This activation subsequently enhances translation efficiency and promotes protein synthesis by phosphorylating S6K and activating the translation factor eIF4B (144)
Within 12 min after secretion, it is degraded by the enzyme dipeptidyl peptidase-4 (DPP-4), which sharply limits its therapeutic potential
The medication doesn't specifically "make you poop" in the sense of acting as a laxative, but rather modifies your overall digestive transit and function
Many patients taking GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) experience digestive side effects including nausea, bloating, and altered bowel habits
Hepatocyte proliferation and gene expression induced by tri-iodothyronine (T3) in vivo and in vitro
Figure 2 illustrates Application Advances of Antioxidant Therapy in Human Studies